Skip to main content
. 2018 Jun 23;41(8):1572–1578. doi: 10.2337/dci18-0003

Figure 2.

Figure 2

Comparison of time in target ranges during the 2-week run-in phase using open-loop pump settings to data from the 3-month HCL period for pediatric participants (aged 7–13 years old) in the 670G trial (30).